Medical Economics January 21, 2025
Key Takeaways
- The Medicare $2 Drug List Model aims to improve medication adherence and prescriber satisfaction by offering low-cost generic drugs.
- ACP supports the model but stresses the importance of monitoring its implementation to prevent negative impacts on prescribers and patients.
- The model includes 101 medications across 15 clinical categories and allows for flexibility in updating the drug list.
- ACP advocates for timely communication of changes to the drug list to ensure uninterrupted treatment for patients.
The potential CMS model would set a $2 copayment for common generic drugs in an effort to improve medication adherence.
In response to a request for information, the American College of Physicians (ACP) expressed their support for the aim of the Medicare...
Today's Sponsors
Today's Sponsor
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Physician, Provider